Democrats lead by 3 points on a generic ballot against Republicans with the midterms less than three weeks out, according to a new poll. The AARP poll, released Thursday, found 49 percent of ...

Add Yahoo as a preferred source to see more of our stories on Google. Democrats lead by 3 points on a generic ballot against Republicans with the midterms less than three weeks out, according to a new ...

Democrats have a 7-point advantage on the generic congressional ballot with three weeks to go before the midterm elections, according to a new poll. The NewsNation and Decision Desk HQ (DDHQ) poll ...

Democrats are leading Republicans on the generic congressional ballot by 7 points, according to a new poll — underscoring the Democrat-friendly environment three weeks out from Election Day. An ...

Four weeks before the November 3 US midterm elections, Republicans trail Democrats by 9.6 points on the generic ballot in analyst Nate Silver’s midterm forecast model. Democrats led by 9.1 points in ...

President Donald Trump visited Maryland on Tuesday to announce a project that's expected to support 14,000 jobs and become the state's largest job creator in over a decade. The president toured ...

President Trump was elected in 2024, in large measure, with a mandate to bring down prices. But that hasn't happened. Instead, Trump is facing record-low approval ratings, and voters are blaming him ...

First-to-market launch brings a lower-cost riociguat to U.S. patients living with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension AHMEDABAD, India and PENNINGTON, N.J ...

Stay ahead of every shift in generics and biosimilars. Generics Bulletin brings you the latest updates that matter for the off-patent industry.

Cheap labor and global supply chains are among the obstacles to President Trump’s plan to bring generic drug manufacturing back home. Credit...Video by Harsha Vadlamani Supported by By Alex Travelli ...

Illinois residents who purchased a generic drug between May 2009 and December 2019 could be eligible for payouts as part of a series of allegations that drug companies conspired to manipulate prices.

The attorneys general from many states have reached settlements with certain major prescription drug makers to resolve claims that alleged the companies illegally agreed to fix the prices of over 100 ...